These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 6427329)

  • 1. Differential expression of cell activation markers after stimulation of resting human B lymphocytes.
    Kehrl JH; Muraguchi A; Fauci AS
    J Immunol; 1984 Jun; 132(6):2857-61. PubMed ID: 6427329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human B cell activation and cell cycle progression: stimulation with anti-mu and Staphylococcus aureus Cowan strain I.
    Kehrl JH; Muraguchi A; Fauci AS
    Eur J Immunol; 1984 Feb; 14(2):115-21. PubMed ID: 6199210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential requirements for cell cycle progression of resting human B cells after activation by anti-Ig.
    Muraguchi A; Kehrl JH; Butler JL; Fauci AS
    J Immunol; 1984 Jan; 132(1):176-80. PubMed ID: 6197443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human B cell responsiveness to B cell growth factor after activation by phorbol ester and monoclonal anti-mu antibody.
    Suzuki T; Butler JL; Cooper MD
    J Immunol; 1985 Apr; 134(4):2470-6. PubMed ID: 2982946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective suppressive effects of glucocorticoids on the early events in the human B cell activation process.
    Bowen DL; Fauci AS
    J Immunol; 1984 Oct; 133(4):1885-90. PubMed ID: 6206141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human B cell activation by diterpine forskolin: interference with B cell growth factor-induced G1 to S transition of the B cell cycle.
    Muraguchi A; Miyazaki K; Kehrl JH; Fauci AS
    J Immunol; 1984 Sep; 133(3):1283-7. PubMed ID: 6086754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification of human B cell activation by a monoclonal antibody to the B cell-specific antigen CD22, Bp 130/140.
    Pezzutto A; Dörken B; Moldenhauer G; Clark EA
    J Immunol; 1987 Jan; 138(1):98-103. PubMed ID: 3097151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
    Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M
    Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of human B cells: alternate options for initial triggering and effects of nonmitogenic concentrations of anti-IgM antibodies on resting and activated cells.
    Smeland EB; Beiske K; Ohlsson R; Holte H; Ruud E; Blomhoff HK; Jefferis R; Godal T
    J Immunol; 1987 May; 138(10):3179-84. PubMed ID: 3553323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of T cell factors in activation, cell cycle progression, and differentiation of human B cells.
    Jelinek DF; Lipsky PE
    J Immunol; 1985 Mar; 134(3):1690-701. PubMed ID: 3871457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDW40).
    Ledbetter JA; Shu G; Gallagher M; Clark EA
    J Immunol; 1987 Feb; 138(3):788-94. PubMed ID: 3492534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligation of the CD23,p45 (BLAST-2,EBVCS) antigen triggers the cell-cycle progression of activated B lymphocytes.
    Gordon J; Rowe M; Walker L; Guy G
    Eur J Immunol; 1986 Sep; 16(9):1075-80. PubMed ID: 2428624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The monoclonal antibodies Trop-4 and 4F2 detect the same membrane antigen that is expressed at an early stage of lymphocyte activation and is retained on secondary lymphocytes.
    Suomalainen HA
    J Immunol; 1986 Jul; 137(2):422-7. PubMed ID: 3487571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell growth and differentiation factors interact with receptors distinct from the interleukin 2 receptor.
    Kehrl JH; Grove JH; Goldsmith PK; Fauci AS
    Eur J Immunol; 1986 Jul; 16(7):761-6. PubMed ID: 3013645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cell sensitivity to natural killing: correlation with target cell stage of differentiation and state of activation.
    Storkus WJ; Dawson JR
    J Immunol; 1986 Mar; 136(5):1542-7. PubMed ID: 3081629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and function of an early activation marker restricted to human B cells.
    Kikutani H; Kimura R; Nakamura H; Sato R; Muraguchi A; Kawamura N; Hardy RR; Kishimoto T
    J Immunol; 1986 Jun; 136(11):4019-26. PubMed ID: 3084651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delineation and characterization of human B cell subpopulations at various stages of activation by using a B cell-specific monoclonal antibody.
    Kikutani H; Nakamura H; Sato R; Kimura R; Yamasaki K; Hardy RR; Kishimoto T
    J Immunol; 1986 Jun; 136(11):4027-34. PubMed ID: 2422270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The B cell surface molecule B1 is functionally linked with B cell activation and differentiation.
    Tedder TF; Boyd AW; Freedman AS; Nadler LM; Schlossman SF
    J Immunol; 1985 Aug; 135(2):973-9. PubMed ID: 3925015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.
    Maruyama S; Kubagawa H; Cooper MD
    J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivity of Leu-1+ tonsillar B cells to a high molecular weight B cell growth factor.
    Richard Y; Leprince C; Dugas B; Treton D; Galanaud P
    J Immunol; 1987 Sep; 139(5):1563-7. PubMed ID: 3114370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.